This HTML5 document contains 9 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

PrefixNamespace IRI
n9http://dbkwik.webdatacommons.org/ontology/
dctermshttp://purl.org/dc/terms/
n7http://dbkwik.webdatacommons.org/resource/Bg1pOYny1Hey7xc3T3ThDg==
n6http://dbkwik.webdatacommons.org/resource/cD9uGk5AoEq0Sl-Sa5Xhcw==
n2http://dbkwik.webdatacommons.org/resource/19Y7Z74NrhvVgIfzoNnh7w==
rdfshttp://www.w3.org/2000/01/rdf-schema#
n5http://dbkwik.webdatacommons.org/resource/02ojvTgWyE1GomeeEyb0IA==
n10http://dbkwik.webdatacommons.org/resource/cJ0jOjXbwV92kNkdODn6fQ==
n4http://dbkwik.webdatacommons.org/resource/kk6z-BONX4D8PD65wAr1GQ==
n11http://dbkwik.webdatacommons.org/resource/mYoIi2QjFUMonEAvQPbC8A==
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
xsdhhttp://www.w3.org/2001/XMLSchema#
Subject Item
n2:
rdfs:label
Promotion of FDA-Regulated Medical Products Using the Internet and Social Media Tools
rdfs:comment
On November 12 and 13, 2009, the Food and Drug Administration (FDA) held a public meeting titled Promotion of FDA-Regulated Medical Products Using the Internet and Social Media Tools to discuss issues related to the promotion of FDA-regulated medical products on the Internet and social media tools. Following the hearing, the FDA and solicited written comments through a public docket that was open from September 2009 to February 2010.
dcterms:subject
n4: n5: n6: n7: n10: n11:
n9:abstract
On November 12 and 13, 2009, the Food and Drug Administration (FDA) held a public meeting titled Promotion of FDA-Regulated Medical Products Using the Internet and Social Media Tools to discuss issues related to the promotion of FDA-regulated medical products on the Internet and social media tools. The following issues were identified: responding to unsolicited requests; fulfilling regulatory requirements when using tools associated with space limitations; fulfilling post-marketing submission requirements; online communications for which manufacturers, packers, or distributors are accountable; use of links on the Internet; and correcting misinformation. Following the hearing, the FDA and solicited written comments through a public docket that was open from September 2009 to February 2010. Following this meeting the FDA did not issue any guidelines, but stated that it would "look at [Internet] issues on a case-by-case basis," while reserving the right to revaluate the need for regulations in the future.